These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38408701)

  • 1. Clinicopathological Analysis of Densely and Sparsely Granulated Somatotroph Tumors of Pituitary.
    Wang L; He X; Lu L; Chen L; Peng C; Shao C; Ge R
    World Neurosurg; 2024 May; 185():e713-e720. PubMed ID: 38408701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis.
    Vuong HG; Dunn IF
    Pituitary; 2023 Dec; 26(6):653-659. PubMed ID: 37735314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.
    Dottermusch M; Ryba A; Ricklefs FL; Flitsch J; Schmid S; Glatzel M; Saeger W; Neumann JE; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):16. PubMed ID: 38228887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern.
    Kim K; Kim Y; Kim SH; Moon JH; Kim EH; Lee EJ; Oh CM; Ku CR
    Front Oncol; 2024; 14():1423606. PubMed ID: 39139281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
    Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
    Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly.
    Swanson AA; Erickson D; Donegan DM; Jenkins SM; Van Gompel JJ; Atkinson JLD; Erickson BJ; Giannini C
    Pituitary; 2021 Apr; 24(2):192-206. PubMed ID: 33074402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
    Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
    Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
    Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Endoscopic Transsphenoidal Approach for More Aggressive Pediatric Pituitary Adenomas: Early- and Late-Term Results from a Single Center Experience.
    Caklili M; Yilmaz E; Duman Ozturk S; Uzuner A; Yildirim P; Cizmecioglu Jones FM; Tas A; Cabuk B; Anik I; Ceylan S
    World Neurosurg; 2023 Aug; 176():e623-e633. PubMed ID: 37271260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment.
    Trouillas J; Vasiljevic A; Lapoirie M; Chinezu L; Jouanneau E; Raverot G
    Minerva Endocrinol; 2019 Jun; 44(2):129-136. PubMed ID: 30531694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.
    Yamato A; Nagano H; Gao Y; Matsuda T; Hashimoto N; Nakayama A; Yamagata K; Yokoyama M; Gong Y; Shi X; Zhahara SN; Kono T; Taki Y; Furuki N; Nishimura M; Horiguchi K; Iwadate Y; Fukuyo M; Rahmutulla B; Kaneda A; Hasegawa Y; Kawashima Y; Ohara O; Ishikawa T; Kawakami E; Nakamura Y; Inoshita N; Yamada S; Fukuhara N; Nishioka H; Tanaka T
    Commun Biol; 2022 Nov; 5(1):1304. PubMed ID: 36435867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
    Lee CC; Vance ML; Lopes MB; Xu Z; Chen CJ; Sheehan J
    Pituitary; 2015 Jun; 18(3):326-34. PubMed ID: 24925503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.
    Obari A; Sano T; Ohyama K; Kudo E; Qian ZR; Yoneda A; Rayhan N; Mustafizur Rahman M; Yamada S
    Endocr Pathol; 2008; 19(2):82-91. PubMed ID: 18629656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulation Patterns of Functional Corticotroph Tumors Correlate with Tumor Size, Proliferative Activity, T2 Intensity-to-White Matter Ratio, and Postsurgical Early Biochemical Remission.
    Durmuş ET; Kefeli M; Mete O; Çalışkan S; Aslan K; Onar MA; Çolak R; Durmuş B; Cokluk C; Atmaca A
    Endocr Pathol; 2024 Sep; 35(3):185-193. PubMed ID: 39046680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically silent somatotroph adenomas are common.
    Wade AN; Baccon J; Grady MS; Judy KD; O'Rourke DM; Snyder PJ
    Eur J Endocrinol; 2011 Jul; 165(1):39-44. PubMed ID: 21493729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly.
    Tomasik A; Stelmachowska-Banaś M; Maksymowicz M; Czajka-Oraniec I; Raczkiewicz D; Zieliński G; Kunicki J; Zgliczyński W
    Front Endocrinol (Lausanne); 2022; 13():957301. PubMed ID: 36187106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.